{"title":"Levofloxacin reposition-based design: synthesis, biological evaluation of new levofloxacin derivatives targeting topoisomerase II beta polymerase as promising anticancer agents, molecular docking, and physicochemical characterization","link":"http://pubs.rsc.org/en/Content/ArticleLanding/2024/RA/D4RA03975K","date":null,"content":"<div><p><img src=\"/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D4RA03975K\" /></p></div><div><i><b>RSC Adv.</b></i>, 2024, <b>14</b>,28098-28119<br /><b>DOI</b>: 10.1039/D4RA03975K, Paper</div><div><img alt=\"Open Access\" src=\"http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png\" /> Open Access</div><div><a href=\"http://creativecommons.org/licenses/by/3.0/\" target=\"_blank\"> <img src=\"http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY.png\" alt=\"Creative Commons Licence\" /></a>Â  This article is licensed under a <a href=\"http://creativecommons.org/licenses/by/3.0/\" target=\"_blank\">Creative Commons Attribution 3.0 Unported Licence.</a></div><div>Zeinab Mahmoud, Mohamed M. Ismail, Mona Kamel, Amira Youssef<br />Repositioning of already approved medications through repurposing or re-profiling for new medical uses after certain structural modifications is a novel approach in drug discovery.<br />The content of this RSS Feed (c) The Royal Society of Chemistry</div>","author":"","siteTitle":"RSC - RSC Adv. latest articles","siteHash":"da3e282678330308414c63a405ade89dd3738fcce2936ca8a2fe3a6d7e967d99","entryHash":"498cdfd2029ea845fdaccb28031095877eaa1a5956911375d9dced4e2e742b02","category":"Environment"}